-
Vijaya Diagnostic Share Price: 35.6% CAGR in 3 Years as This Relatively New Lab Chain Takes On Dr Lal PathLabs, Metropolis and Thyrocare
- November 4, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
No Comments
Vijaya Diagnostic share price compounded at 35.6% a year over 3 years. See how it compares with Thyrocare, Metropolis and Dr Lal PathLabs on returns and ROE.
-
This Diagnostic Chain Stock Rises 43% in 1 Year
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
One southern pathology and radiology network gained 43% in a year on five straight quarters of margin expansion. Here is what drove the move and where the risks sit.